The Action of Plasmochin on Malaria.
By PHILIP MANSON-BAHR, D.S.O., M.D., F.R.C.P. THE introduction of a new drug possessing a specific action upon the malaria parasite is an event of the first importance in the realm of tropical medicine. For now nearly three centuries quinine obtained from the bark of the cinchona tree, Cinchonca succirubra (and its cultivated varieties) has been regarded for generations of physicians as the one example of a specific drug with a specific action upon a specific parasite. Alas! like many other shibboleths in medicine, more prolonged and intimate observations upon the action of quinine, or in fact any of the allied alkaloids of the bark, have shown that in many respects it fails to reach the ideal Therapia magna sterilisans of Ehrlich. Though there cannot be any doubt about its therapeutic excellence in the treatment of malaria, far less reliance is placed upon quinine as a means of extirpating malaria than was formerly the case; for this dubiousness the experiences of the Great War, and that gained since the cessation of hostilities, have been largely responsible.
The name of cinchona bears testimony to the efficacy of quinine in the historic case of the Countess of Chinchon in 1638. About that time the first samples of cinchona bark reached Europe, and it is to the great Thomas Sydenham, the English Hippocrates (then in practice at Charing Cross) that we owe the introduction of the Peruvian bark to British medicine. Sydenham's advocacy of this drug in the quartan fevers so prevalent at that time (1666) is also well known.
A distinct advance in the therapeutics of malaria was made in 1820 by the isolation by Pelletier and Caventon of the alkaloid-quinine-from the bark.
The chief constituents of the cinchona bark are now known to be quinine (about 1 5 per cent.), cinchonidine (2 5 per cent.), cinchonine (1 per cent.), some quinidine, hydroquinine, hydrocinchonidine, and some other allied bodies making up a total of about 5 8 per cent. alkaloid. The action of these allied alkaloids on malaria has been more or less thoroughly tested, but it may be said that, with the exception of quinidine, their effect upon the malaria parasites is indeed negligible.
Ever since 1907 (Rabe) I the formula of quinine is known to be a complicated one and to be a combination of a quinoline with a piperidine ring 
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But so far the complete synthesis of the quinine molecule has not been accompulished in the laboratory. The attention of synthetic chemists in Germany, as well as in other countries, has been focused for some time l)ast on the production in the laboratory of some organic combination of the quinoline ring which would exert a much more specific action upon the malaria l)arasite, and which would, at the same time, be free from the attendant toxic phenomnena which sometimes accompany the action of this drug.
In pharmaceutical laboratories at Elberfeld, H. H6rlein,l in analysing the alkaloid, has produced a coimlplicated body known as alkylamino-6-methoxyquinoline. In so doing a great many combinations of.side chains to the quinoline ring have been attempted, but of these so far one only, ethylaminoquinoline-hydrochloride, has been found to be well tolerated and at the same time to exert a toxotropic action upon plasmodia allied to the malaria parasites.
The detailed formula for plasmochin (plasmoquine), as it is now known, has not as yet been definitely stated, except in the general terms outlined above. For a short time subsequent to the discovery of plasmochin in 1925, the substance was referred to as Beprochin.
The preliminary experimental work and the estimation of the toxic and therapeutic dosages of plasmochin have been worked out in chemotherapeutic laboratories at Elberfeld, by Dr. W. Roehl.2 The investigator has based his work upon the demonstration by Kopanaris, later by the brothers Sergent in Algiers, and by Giemsa in Hamburg, that quinine, when injected into canaries infected with the plasmodium allied to malaria (Plasmodium pr.Tcox vel Plasmodimun relictum), rapidly banishes those parasites from the circulation; in addition Marks, in the Ehrlich Institute at Frankfurt, has shown that various other bodies, such as the basic stains and methylene blue, exert a definite action on bird malaria.
The difficulty in assessing the correct chemotherapeutic action of these recently elaborated drugs, and the determination thereby of the therapeutic dosage in man, lies in the technique of administration. When mixed with the food of infected canaries it is readily understood that no exact account can be kept of the actual amount of the drug ingested. By injecting the drugs in watery solution subcutaneously, or into the muscles of the breast, it was soon found that the poisonous alkaloids exerted a definite local action which in most cases was rapidly fatal to the birds. Roehl adopted the method, which has proved successful, of injecting the suibstances directly into the stomach by means of a specially constructed pipette about the thickness of a ureteric catheter. A canary of 20 grm. body-weight could be injected with 1 c.c. of a 1: 200 quinine solution. A regular system was instituted and hundreds of canaries were infected with proteosoma by direct intramuscular injection of infected blood.
Experiments were conitrolled by daily microscopic blood-examination from the veins of the wings.
With quinine injections given daily for six days, the parasites appear in the blood after an interval of ten to twelve days, whereas in untreated birds they are to be seen on the fifth day after infection. By a method of this kind he has been enabled to form a scale of therapeutic standards, and during three years he succeeded in working through a large number of compounds in a search for one which exerted a more definite specific action on proteosoma than does quinine. Such a substance proved to be plasmochin, which was found to be tolerated by the bird in a dilution of 1: 1500 and to give a therapeutic action of from 1: 1500 to 1: 50000; on calculations based on the principles enunciated above, plasmochin was found to exert a parasitotropic action sixty times greater than quinine.
1 Horlein, H., Archivf. Schiff8-ui. Tropenhyg. (Beiheft), 1926, xxx, No. 3, pp . 5-10.
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With a dilution of 1:50000 of plasmochin the parasites appear in the blood of birds infected with proteosoma after an interval of ten days, with stronger solutions they are delayed up to six weeks, sometimes not appearing at all. One remarkable observation emerged from these experiments: that the sexual forms of proteosoma (gametocytes) were destroyed apparently much more readily than the schizonts, whereas the reverse is the case with quinine.
Within a short period after the conclusion of these chemotherapeutic experiments, the' action' of plasmochin was tested' out (1925) by SioliI in " therapeutic malaria " in general paralytics infected with the benign tertian parasite. The doses at first sight appeared small, and ranged from 0 05 up to 0 -25 grm. daily. The latter, however, was found to be too large, and the patient developed a curious cyanosis with blue lividity of the skin and nails. The blood became chocolate-brown in colour. In one instance the patient himself was partially collapsed and vomited. After four days the condition cleared up.
Forty cases were treated with plasmochin, with the result that the parasites disappeared from the blood. The safest dose was found to be about 0s 1 grm. daily;
with smaller doses relapses of malaria recurred. Eventually a dose of 0(08 grm. was exhibited for three days subsequent to the disappearance of the parasites from the peripheral blood, and repeated for a four days' course weekly for a period of three weeks.
The drug was first given in capsules, but later in a compressed tablet form which was extensively used by Miihlens' in a series of 134 naturally acquited malaria cases in Hamburg. His experience of the dosage agrees on the whole with that of Sioli, namely, that 0h 1 grm. of plasmochin daily is the therapeutic dose, and that doses of 0 15 grm. and higher are liable to be attended by dangerous toxic phenomena. Finally, it was found best to administer the drug in five doses of 0 *02 grm. in tablet form daily; and these were found to be practically tasteless. The action of the drug on benign and quartan malaria was found to be rapid and satisfactory, but in some subtertian infections parasitic relapses occurred while the patient remained under treatment.
With larger doses of plasmochin cyanosis was observed often accompanied by colicky pains, which Miihlens regarded as the effects of a vasomotor disturbance.
More recently (1926) from experiments on animals by Eichholtz, as well as from the clinical observations of Schulemann and Memmi in Grosseto (Italy), it has been ascertained that the plasmochin cyanosis rapidly disappears on subsequent quinine treatment-in other words, quinine and plasmochin are antagonistic to one another in this respect.
Owing to the comparatively short time the patients were able to spend in hospital, and owing to the difficulty of " following them up," Muhlens has been unable to ascertain in what proportion of cases actual relapses of malaria occurred, subsequent to treatment. Although the action of plasmochin on the ring forms of the subtertian parasite proved to be so uncertain, it was found, to his astonishment, to exercise the most remarkable action upon the gametocytes or crescents, which entirely disappear from the circulation within a period of four to seven days, whereas it is well known that on the generally accepted quinine therapy they may persist from four to six weeks. Thus a new method of sterilizing the blood of carriers of this infection is undoubtedly at hand. The expla'nation of this phenomenon is at present not apparent.
Better results were obtained in subtertian infections by the combination of' I Sioli, F., Archiv f. Schiffs. u. Tropenhyg. (Beiheft), 1926, xxx, No. plasmochin with small doses of quinine, especially in relapse cases, and this is now the basis of tablets known as "Plasmochin Compound," each tablet containing 0 01 grm. plasmochin + 0 125 grm. quinine sulphate. On six of these tablets daily (0 * 06 grm. plasmochin (T9j gr.) + 0 75 grm. quinine (12 gr.) ) the best results were obtained in both benign and subtertian infections, of which twenty-five cases were treated in all, though sufficient interval had not elapsed in order to ascertain whether the cures were permanent.
Schulemann and Memmi now state that in subtertian malaria plasmochin compound gives the most permanent results if it is administered consecutively for fourteen days in a dosage of six tablets daily, and then for four days weekly for the subsequent five weeks.
Through the generosity of the manufacturers, I have been provided, since the beginning of 1926, with a sufficient quantity of plasmochin and plasmochin compound for experimental purposes. At first the plasmochin was supplied in capsules and latterly in the form of tablets, each containing 002 grm. of the drug.
During the past year I have been able to treat some eighteen cases of malaria with plasmochin alone, and an additional ten with plasmochin compound, making a total of twenty-eight cases.
While admitting that this is not a very large series on which to base far-reaching conclusions, yet I would submit, as will be seen from the charts which I exhibit, that the records have been kept with extreme care and the cases have been followed up during a period of nine months, or a year in some instances, in order to verify tHe occurrence of relapses. While the cases have been under observation, and while undergoing plasmochin treatment, daily blood examinations by thick and thin films have been made in order to estimate accurately the number of parasites in the peripheral blood, and in order to observe the disappearance of the various forms of parasite in order of precedence. Minute observations have been made upon the urine and the content of urobilinogen; these laboratory observations have been combined with daily examination and measurements of the spleen.
I have been able to confirm fully the work of previous observers (cf. Sioli and Miihlens) which I have already mentioned, namely:-(a) Plasmochin in doses up to 0 * 08 to 0 1 grm. daily causes a rapid disappearance of benign tertian parasites from the peripheral blood within twenty-four hours of its administration, and when this dosage is continued over a period of five to seven days, the banishment of the parasite appears to be in some instances permanent.
(b) Plasmochin in the same dosage as is efficacious in benign tertian infections does not in every instance banish the schizonts of the subtertian parasite in the same manner.
(c) The gametocytes of the benign as well as of the subtertian parasite are first affected. The crescents of the latter-even when numerous-disappear from the blood within four days.
(d) The extraordinarily rapid action of the drug in reducing the size of the spleen is remarkable. By daily measurements it has been shown that a spleen measuring 6 in. in the nipple line recedes well within the costal margin in a period of nine to ten days, so that it is no longer palpable. The rapid contraction of the spleen is often accompanied by a sensation of pain and discomfort over the splenic area.
(e) The appearance of urobilinogen in pathological amounts in the urine coinciding with the administration of the drug and persisting for several days subsequently.
(f) The appearance of a deep cyanosis involving, at first the face, and subsequently the whole body, with doses in excess of 0 08 grm. daily, has been noted; this cyanosis being due to a methismoglobinsBmia, which, if too intense, may develop into methamoglobinuria.
(1) Benign Tertian Infections.
(1) L., a patient, aged 60, with incipient general paralysis of the insane, inoculated with benign tertian malaria.-After an incubation period of eighteen days he developed typical malarial rigors and had eleven rigors on as many consecutive days.
Benign tertian parasites were extremely numerous in the blood, and often as high as 3,600, against a count of 200 leucocytes. The proportion of gametocytes varied greatly on different days.
A total amount of plasmochin of 0 48 grm. was given, commencing on March 25, 1926, and within two days all the parasites had disappeared from the peripheral blood, while the patient has been free from malarial rigors ever since.
No symptoms referable to the drug were noted.
(2) J. G., a boy, aged 8i years, sent home from India on account of intractable malaria from which he had suffered for 1i years. Arrived in England April 10, 1926, bi-weekly recurrences with rigors (T. 105) for the subsequent five weeks, 126 B.T. parasites per 200 leucocytes. Total quantity of plasmochin 0 * 46 grm. Has returned to school and remained in good health ever since. The rapid reduction in the size of the spleen was a noticeable feature. Daily dose of plasmochin was 0 04 grm.
(3) P., Indian student with enlarged spleen and rigors. In addition to these there have been four other cases of B.T. injections treated in the same manner with equally favourable results (in two the inoculation period of their malaria after arrival in this country from the tropics was eight months and ten months respectively).
(2) Siubtertian Infections.
(1) G., Indian Army officer. Recurrent subtertian malaria, quinine idiosyncrasy, T. 1030 F. Enlarged spleen. Fifteen parasites to 200 leucocytes, crescents present. Total amount plasmochin 1 4 grm., daily dosage 0*12 grm. Rapid improvement in health and reduction in size of spleen. Admitted January 26, 1926 ; has remained in good health since.
(2) H., from India. Railway servant invalided from Bombay on account of intractable subtertian malaria; failure of quinine. Enlarged spleen, icterus, anaemia. Treatment commenced February 4, 1926. Total amount of plasmochin 2 0 grm. Rapid disappearance of numerous crescents. Failure of plasmochin. Parasitic and clinical relapses, eventual recovery on combined quinine and plasmochin therapy.
( (2) W. W. C., miner from Colombia, February 22, 1926. Large aneurysm of ascending arch of aorta. T. 105°F., enlarged spleen, double infection, benign tertian rings and numerous crescents. Rapid disappearance of crescents and reduction in size of spleen. Total plasmochin, O * 96 grm. Relapse of benign tertian malaria six months later.
Thus it will be seen that the action of plasmochin on the subtertian parasite was by no means satisfactory and required reinforcement with quinine. In addition to this cyanosis developed in three cases out of eight.
Considerations of the Cyanosis produced by Plasmochin. This is undoub'tedly a toxic phenomenon, which develops with great suddenness. The cyanosis is'first to be observed on the mucous membrane of the lower lip, and shortly afterwards the palate, gums and finger-nails become involved. The face assumes a livid grey tint. At the same time the patient is not unduly distressed; there is no dyspncea or increased pulse-rate.
Two of the patients complained of curious clammy sweats, abdominal pains and a bruised sensation over the ribs which I assumed to be due to spasmodic contraction of the spleen. The blood, when shed, was of a chocolate-brown colour and the discoloration appears to be due to the conversion of the oxyhaWmoglobin contents of the red cells with methsemoglobin. The first patient had a double infection of benign and subtertian parasites, and' a markedly positive Wassermann reaction. After 0 4 grm. plasmochin (in doses of 0*12 grin. daily), the violetcoloured cyanosis developed at a temperature of 101.40 F., and within twenty-four hours methaemoglobin appeared in the urine with albumin and amorphous casts. The blackwater symptoms lasted two days and were accompanied by typical htemolytic icterus with the destruction of one and a half million red blood-corpuscles per cubic millimetre of blood. The attack resembled a mild blackwater fever, .which ran a favourable course. Both species of malaria parasites disappeared during the attack, and the cyanotic state lasted twenty-four hours.
In the second case, which was one of a pure subtertian infection, the cyanosis became apparent after the patient had taken 0 24 grm. of plasmochin (i.e., three days of 0-08 grm. daily). The drug was immediately stopped, but the lividity of lips and skin lasted exactly seven days; it was accompanied by a considerable degree of abdominal pain, nausea and pain in the back. Apart from urobilinogen in the urine no other pigments were observed.
The third case was also a subtertian infection, but here the cyanosis was of only slight degree, and involved the mucous membrane of the mouth, lips and fingers. There was a considerable amount of abdominal pain in the epigastrium, and a painful sensation over the ribs and splenic area. On cessation of administration of the drug all subjective symptoms disappeared.
Although apparently more prone to develop in the subtertian, this plasmochin cyanosis may develop in benign tertian infection, as has been recorded by Sioli.
This toxic manifestation of plasmochin is an interesting phenomenon and appears to be analogous to the methmemoglobineemia of potassium chlorate poisoning. In susceptible individuals it may apparently occur after comparatively small doses of plasmochin.
Plasmochin is free from the bitter taste of quinine; it has not a diagreeable flavour and exerts a curious anesthetic effect on the tongue and buccal mucosa. PLASMOCHIN COMPOUND. I have already referred to the combination of plasmochin and quinine, which is put.up in the form of tablets, eaclh containing 0 01 grin. plasmochin and 0 125 grm. of quinine. During the past year I have treated ten cases of malaria, five of which were benign, and an equal number subtertian infections (two of the latter with numerous crescents). As compared with the points already noted regarding plasmochin, the disappearance of the parasites from the peripheral blood-stream was not effected so rapidly, but improvement in the clinical condition was striking, and was accompanied by an equally rapid reduction in the size of the spleen. No unpleasant sequele have been observed after the administration of plasmochin compound, and it also appears to be free from the usual accompaniments of quinine therapy. No cyanosis has been observed with this combination. The advantage of plasmochin compound over quinine is obvious, though it is yet far too early to state positively whether the apparent cure of a malaria relapse is permanent. A sufficiently long period has not yet elapsed since these cases were treated to enable one to be positive on this point.
The following course of treatmyent is suggested as being the most efficacious with Ilasmochin compound for an adult with the main forms of malaria.
For five days, plasmochin compound (2 tablets x 3 daily).
For four days, rest.
For three days, plasmochin compound (6 daily). For four days, rest.
For three days, plasmochin compounJ (6 daily).
For two days, plasmochin compound (6 daily).
For five days, rest.
For two days, plasmochin compound (6 daily). As far as my experience has gone plasmochin compound is more efficacious in subtertian malaria than is plasmochin alone.
From my recent experiences with this new drug in what I must admit are a limited number of cases, I have endeavoured to sum up my conclusions in a spirit as free from bias as possible. It must be admitted, I think, that a definite addition has been made to our therapeutic armamentarium against malaria by the introduction of plasmochin. That the drug, as at first elaborated, has certain definite disadvantages is incontestable, but these seem to be discounted by the addition of minute doses of pure quinine. Finality in the drug treatment of malaria has by no means been obtained, but it is permissible to be enthusiastic, though not too optimistic about plasmochin. One great advance has been made which it has been my duty to record, namely, its extraordinary selective action upon the crescents or subtertian gametocytes. That, indeed, in itself is hopeful and it is safe to augur that plasmochin is but the first of a similar series of synthetic comipounds which may extirpate the malaria infection without at the same time eliciting any toxic symptoms. Plasmochin should therefore be regarded as the beginning and not as the climax of a new series of anti-malaria drugs. I am greatly indebted to my house physician, Dr. Stuart Anderson, for his assiduity and assistance in preparing the charts shown during the reading of this paper, and to Dr. H. B. Newham and Mr. Foster for the care they lavished on the microscopic blood examinations upon which these observations are based.
Di8CUssion.-Dr. J. GORDON THOMSON said that both natural and acquired immunity to malaria existed. The latter was a tolerance which developed after repeated infections over a long period and occurred where the disease was hyperendemic. If such persons were removed they lost this acquired immunity. In avian malaria the bird had an acute disease for about 9W5 nine days, after that the disease decreased and a partial tolerance was developed, which might remain for nearly two years. The blood, however, was still infective for other birds and for mosquitoes. The bird was not cured and if its resistance fell the disease might again become acute. He (Dr. Thomson) asked whether plasmochin really cured the disease or merely caused a tolerance. Natural immunity in malaria also existed and some patients recovered without any specific treatment. These facts would have to be taken into consideration before plasmochin could be said to possess any advantages over quinine. Plasmochin seemed to be of little use in malignant tertian malaria, which, however, was more amenable to treatment with quinine than benign tertian. The factor of safety of the drug appeared to be very low-this was a definite disadvantage.
Dr. G. C. Low said that he had only used plasimochin a few times, and that therefore he was not entitled to speak very definitely about the matter. He had seen the cyanosis, described by Dr. Manson-Bahr, in a case of benign tertian malaria, and also had seen a case of severe lumbar pain, probably renal in nature, in a malignant tertian infection treated with this drug. In dealing with a new drug for malaria it must be remembered that we already had a good one in quinine, so that any new drug recommended would have to be super-excellent to beat it. As far as he could see it was too early to say that plasmochin was better, and more work was required to determine its value, especially in following up cases to see whether relapses took place. Again, more work was required to determine its effect upon the crescents in malignant tertian malaria. It was of no use destroying the gametes-apart from the question of infecting anopheles-if the young forms which produced them were still active. It was a question of the goose and the golden eggs over again. It would be interesting to hear what result other observers obtained. At the moment one might say the drug was much more toxic than quinine, and most certainly it could not be used by the laity without strict medical supervision. He thought he could exhibit charts showing quite as favourable an action, and with equal reduction in the size of the spleen, obtained under proper courses of quinine, plus iron and arsenic.
Perhaps, as Dr. Manson-Bahr had suggested, a combination of quinine and plasmochin might yield better results than either drug alone.
Sir WILLIAM PROUT said that it was very rare indeed to find a true quinine idiosyncrasy, although many people thought that they were unable to take quinine. He had treated thousands of cases of malaria and he had found that the occurrence of inability to take quinine was so rare as to be negligible. Dr. C. R. HENNINGS, in association with, and on behalf of the manufacturers, said, in reply to a previous query, that the drug should be administered under medical care. Dr. Manson-Bahr had perhaps put the dose of plasmochin rather high. According to recent experience 0 * 02 grm., three times a day, had proved to be sufficient. Drugs of this kind-as a further instance of which " Bayer 205 " might be mentioned-always required a considerable amount of time until their value could be definitely established, but it was to be hoped that plasmochin would prove a real contribution towards medical progress.
Dr. MANSON-BAHR, in reply to Dr. J. G. Thomson, said that he had had personal experience of cases of absolute immunity against malarial infection. In one instance a patient had proved resistant, not only to bites of infected anopheles, but also on two occasions to the injection of malaria-infected blood. He was doubtful as to the practicability of provoking a malaria relapse either by the immersion of the patient into an ice-cold bath, or by the intravenous injection of adrenalin. The plasmochin cyanosis could develop in either benign tertian or in subtertian cases, and he understood that overdoses had been produced by Eichholtz in a normal dog. No work had yet been done, but it was certain to be undertaken soon, on the exflagellation of the " crescent " in a plasmochin-treated case. In the cases in which cyanosis had been noted, no evidence of Maurer's dots had been observed.
In answer to Dr. G. C. Low, he stated that the patient in the case of metheemoglobinuria quoted came from British Guiana.
In reply to Sir William Prout he said he believed true cases of quinine idiosyncracy to be extremely rare. In these cases he implied that vomiting and digestive disturbances had been so great that the exhibition of quinine was discontinued; there was also in children the question of disagreeable taste to be considered.
